MiniMed Group Inc (NASDAQ:MMED – Get Free Report)’s share price gapped up prior to trading on Monday. The stock had previously closed at $17.99, but opened at $18.83. MiniMed Group shares last traded at $18.7430, with a volume of 1,355,346 shares changing hands.
Wall Street Analyst Weigh In
Several analysts have issued reports on the stock. Bank of America raised their price target on shares of MiniMed Group from $24.00 to $28.00 and gave the stock a “buy” rating in a research report on Wednesday, September 2nd. Rothschild & Co Redburn started coverage on shares of MiniMed Group in a research report on Tuesday, October 13th. They set a “buy” rating and a $30.00 price objective for the company. Truist Financial started coverage on shares of MiniMed Group in a research note on Thursday, September 24th. They issued a “buy” rating and a $29.00 target price for the company. Wells Fargo & Company lifted their target price on MiniMed Group from $22.00 to $26.00 and gave the stock an “overweight” rating in a research report on Wednesday, September 2nd. Finally, Morgan Stanley boosted their price target on MiniMed Group from $19.00 to $21.00 and gave the company an “overweight” rating in a research note on Thursday, September 3rd. Fourteen analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, MiniMed Group has a consensus rating of “Moderate Buy” and a consensus price target of $24.12.
Read Our Latest Stock Report on MMED
MiniMed Group Stock Performance
The firm’s 50-day moving average price is $19.40 and its two-hundred day moving average price is $16.75. The firm has a market capitalization of $5.00 billion and a price-to-earnings ratio of -26.15.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. New York State Common Retirement Fund acquired a new stake in MiniMed Group during the third quarter valued at approximately $197,000. Quarry LP grew its stake in shares of MiniMed Group by 23,079.6% in the 3rd quarter. Quarry LP now owns 86,228 shares of the company’s stock valued at $1,679,000 after purchasing an additional 85,856 shares during the period. Aquatic Capital Management LLC bought a new stake in shares of MiniMed Group in the 3rd quarter valued at approximately $3,547,000. Jump Financial LLC acquired a new position in shares of MiniMed Group in the 3rd quarter worth approximately $1,980,000. Finally, Marshall Wace LLP acquired a new position in shares of MiniMed Group in the 3rd quarter worth approximately $9,151,000.
About MiniMed Group
MiniMed Group focuses on diabetes technology, developing products and services to help people manage insulin-dependent diabetes. Its offerings include insulin pumps, continuous glucose monitoring systems, infusion sets and software for tracking glucose and coordinating insulin delivery. The business is known for automated insulin-delivery systems that use glucose readings to help adjust insulin delivery, including products in the MiniMed 780G system line. Its technologies are intended for use by people with diabetes and the clinicians who support their care.
Read More
- Five stocks we like better than MiniMed Group
- Disney Has the Magic Touch: Dividend Growth and Buybacks Could Fuel a Breakout
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
Receive News & Ratings for MiniMed Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MiniMed Group and related companies with MarketBeat.com's FREE daily email newsletter.
